Prostaglandin F2 alpha analogs in combination with antimicrobials for treating glaucoma

Details for Australian Patent Application No. 2003222049 (hide)

Owner Cayman Chemical Company, Inc

Inventors Johnson, Jennifer; Maxey, Kirk, M.

Agent Pizzeys

Pub. Number AU-B-2003222049

PCT Number PCT/US03/08935

PCT Pub. Number WO2003/079997

Priority 60/367,071 21.03.02 US

Filing date 21 March 2003

Wipo publication date 8 October 2003

Acceptance publication date 31 May 2007

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 31/557 (2006.01) - Eicosanoids, e.g. leukotrienes

A61K 31/5575 (2006.01)

A61K 38/40 (2006.01) Medicinal preparations containing peptides - Transferrins, e.g. lactoferrins, ovotransferrins

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/367,071 21.03.02 US

13 November 2003 Application Open to Public Inspection

  Published as AU-B-2003222049

4 November 2004 Amendment Made

  The nature of the amendment is: Amend the name of the applicant from Cayman Chemical Company to Cayman Chemical Company, Inc.

31 May 2007 Application Accepted

  Published as AU-B-2003222049

27 September 2007 Standard Patent Sealed

4 August 2011 Alteration of Name

  The name of the patentee has been altered to Cayman Chemical Company, Incorporated 2004

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003222050-Abrasive articles with novel structures and methods for grinding

2003222048-LONG PERIOD CHIRAL FIBER GRATING APPARATUS